Biocompatibility Testing

---

 We offer specialized MTT (Methylthiazolyldiphenyl-tetrazolium bromide) assays to evaluate human cell viability. The MTT assay is a gold-standard method for assessing the cytotoxicity and biocompatibility of materials, medical devices, and compounds. 

 We offer in vitro hemolysis testing using the direct contact method to evaluate the blood compatibility of materials used in medical devices, implants, and other healthcare products. Hemolysis testing is essential to ensure that materials do not cause the destruction of red blood cells, which could lead to adverse reactions in patients. The hemolysis ratio (HR) is calculated to determine the extent of red blood cell rupture, providing an accurate measure of material biocompatibility. 

Protein Adhesion Studies: We quantify protein adhesion using BCA, Bradford, and ELISA assays to analyze material interactions with proteins in biological environments.

Blood Clotting and Thrombin Deactivation: We assess the effects of materials on blood clotting time using a semi-automated coagulometer and measure thrombin deactivation to evaluate anticoagulant properties.

Complement Activation Assays: We analyze complement activation in the blood to assess immune system interactions with materials, ensuring they do not trigger adverse immune responses.

All testing is conducted in accordance with ISO 10993 and other relevant international standards, ensuring that your products comply with global regulatory requirements.